Table 1. Baseline Characteristics by Sample: 2001–2005.
| Unmatched Sample | Conventional PS Matched | TSPS Matched | |||||||
| Olanzapine (N = 7,082) | Other SGAs (N = 13,544) | Olanzapine (N = 6,829) | Other SGAs (N = 6,829) | Olanzapine (N = 6,777) | Other SGAs (N = 6,777) | ||||
| Age | |||||||||
| Age at Index Fill Date – Means (SD) | 42.3 (12.2) | 41.8 (12.6) | 42.2 (12.2) | 42.0 (12.5) | 42.1 (12.2) | 42.2 (12.5) | |||
| 18–29 | 17.9 | 19.9 | 18.3 | 19.1 | 18.3 | 18.6 | |||
| 30–39 | 21.5 | 21.2 | 21.4 | 21.6 | 21.5 | 21.9 | |||
| 40–49 | 30.1 | 28.6 | 30.9 | 29.0 | 30.0 | 28.3 | |||
| 50–64 | 30.5 | 30.3 | 30.2 | 30.3 | 30.2 | 31.2 | |||
| Sex | |||||||||
| Female | 57.5 | 62.1 | 58.1 | 58.1 | 58.0 | 58.1 | |||
| Race | |||||||||
| White | 46.2 | 51.7 | 47.5 | 47.5 | 47.9 | 47.9 | |||
| Black | 17.1 | 18.5 | 17.6 | 17.8 | 17.7 | 17.9 | |||
| Hispanic | 11.1 | 8.1 | 9.8 | 9.7 | 9.5 | 9.4 | |||
| Other/Unknown | 25.6 | 21.7 | 25.1 | 25.0 | 25.0 | 24.9 | |||
| Medicaid Eligibility Category | |||||||||
| Supplemental Security Income | 65.4 | 64.8 | 65.9 | 65.8 | 66.1 | 66.1 | |||
| Prior Health Services Utilization – Mean (SD) | |||||||||
| Number of Outpatient Visits in Prior 6 Months | 16.1 (21.2) | 14.6 (18.4) | 14.5 (18.5) | 14.8 (18.7) | 14.6 (18.5) | 14.7 (18.9) | |||
| Number of Inpatient Visits in Prior 6 Months | 1.8 (3.2) | 2.0 (3.4) | 1.8 (3.2) | 1.8 (3.0) | 1.8 (3.1) | 1.8 (3.2) | |||
| Metabolic and Cardiovascular Risk Factors | |||||||||
| Diabetes | 8.5 | 11.5 | 8.7 | 8.9 | 8.7 | 8.8 | |||
| Hyperlipidemia | 9.3 | 9.6 | 9.0 | 9.2 | 8.8 | 8.4 | |||
| Hypertension | 23.9 | 27.4 | 24.0 | 23.4 | 23.9 | 23.9 | |||
| Obesity | 1.2 | 2.1 | 1.2 | 1.1 | 1.2 | 1.2 | |||
| Peripheral Vascular Disease | 2.2 | 1.6 | 1.9 | 1.7 | 1.6 | 1.8 | |||
| Cerebrovascular Disease | 3.0 | 2.9 | 2.9 | 2.8 | 3.0 | 2.9 | |||